News
Appointment of joint broker
17 February 2012
The board of TyraTech, Inc. (the "Company") (AIM: TYR), a natural life sciences company, is pleased to announce the appointment of First Columbus LLP as joint corporate broker to the Company with immediate effect.
For further information please contact:
TyraTech Inc.
Alan Reade, Executive Chairman
+1 919 415 4310
Peter Jerome, Chief Financial Officer
+1 919 415 4280
N+1 Brewin, Nominated Adviser and Joint Broker
Aubrey Powell/ Robert Beenstock
+44 20 3201 3710
First Columbus LLP, Joint Broker
Chris Crawford
Tel: +44 20 3002 2070
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.